We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$8.14B
AUM Growth
+$473M
Cap. Flow
+$1.3B
Cap. Flow %
15.91%
Top 10 Hldgs %
18.35%
Holding
1,253
New
376
Increased
261
Reduced
225
Closed
366

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$180M
2
ZTS icon
Zoetis
ZTS
+$103M
3
GILD icon
Gilead Sciences
GILD
+$98.1M
4
SHW icon
Sherwin-Williams
SHW
+$85.9M
5
VZ icon
Verizon
VZ
+$79.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.21%
2 Financials 15.39%
3 Communication Services 14.58%
4 Consumer Discretionary 9.63%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSCI icon
651
MSCI
MSCI
$40.9B
$807K 0.01%
13,570
-28,761
-68% -$1.81M
RDS.B
652
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$802K 0.01%
+16,891
New +$910K
CSTM icon
653
Constellium
CSTM
$3.99B
$799K 0.01%
131,883
MCK icon
654
McKesson
MCK
$101B
$798K 0.01%
4,311
-10,437
-71% -$2.21M
DM
655
DELISTED
Dominion Energy Midstream Ptr LP
DM
$796K 0.01%
+29,642
New +$999K
APD icon
656
Air Products & Chemicals
APD
$67.6B
$795K 0.01%
6,739
-46,805
-87% -$5.96M
TEL icon
657
TE Connectivity
TEL
$62.6B
$794K 0.01%
+13,256
New +$807K
TSL
658
DELISTED
Trina Solar Limited
TSL
$794K 0.01%
88,518
PAGP icon
659
Plains GP Holdings
PAGP
$4.9B
$791K 0.01%
16,965
JAH
660
DELISTED
JARDEN CORPORATION
JAH
$789K 0.01%
+16,138
New +$854K
PTCT icon
661
PTC Therapeutics
PTCT
$6.12B
$787K 0.01%
29,484
+12,009
+69% +$514K
SC
662
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$786K 0.01%
38,495
-17,961
-32% -$413K
PDLI
663
DELISTED
PDL BioPharma, Inc.
PDLI
$783K 0.01%
+155,600
New +$892K
MKL icon
664
Markel Group
MKL
$23.2B
$775K 0.01%
+966
New +$817K
WLL
665
DELISTED
Whiting Petroleum Corporation
WLL
$772K 0.01%
169
-58
-26% -$359K
CLVS
666
DELISTED
Clovis Oncology, Inc.
CLVS
$755K 0.01%
+8,208
New +$710K
ITCI
667
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$750K 0.01%
+18,738
New +$611K
STON
668
DELISTED
StoneMor Inc.
STON
$747K 0.01%
+27,396
New +$775K
AVNS
669
DELISTED
Avanos Medical
AVNS
$731K 0.01%
25,699
-1,097
-4% -$38.3K
SLB icon
670
SLB Ltd
SLB
$75B
$728K 0.01%
10,563
-31,911
-75% -$2.53M
RSPP
671
DELISTED
RSP Permian, Inc.
RSPP
$719K 0.01%
35,520
+13,622
+62% +$321K
MWE
672
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
$717K 0.01%
+16,703
New +$952K
FTNT icon
673
Fortinet
FTNT
$117B
$715K 0.01%
84,190
-628,115
-88% -$5.56M
ITG
674
DELISTED
Investment Technology Group Inc
ITG
$714K 0.01%
53,499
+42,402
+382% +$786K
TSN icon
675
Tyson Foods
TSN
$20.4B
$713K 0.01%
+16,553
New +$706K

Similar funds

Marshall Wace's Q3 2015 Portfolio in Review

As of Q3 2015, Marshall Wace held 1,253 positions worth $8.14B, up 6.2% from $7.67B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace deployed $1.3B of net new capital in Q3 2015, opening 376 new positions and adding to 261 existing holdings. Its largest new stake was Alphabet (Google) Class A: 5,575,920 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $137M trimmed.

  • Marshall Wace's largest Q3 2015 buy was Alphabet (Google) Class A: 5,575,920 shares worth $178M.
  • Marshall Wace added most to Zoetis in Q3 2015, an estimated $103M increase.
  • Marshall Wace's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $137M.
  • Marshall Wace fully exited Emerson Electric in Q3 2015, selling an estimated $46.3M.
  • Marshall Wace's ten largest holdings make up 18% of its $8.14B portfolio in Q3 2015.
  • Marshall Wace opened 376 new positions and closed 366 in Q3 2015.
  • Marshall Wace's portfolio value rose 6.2% quarter-over-quarter to $8.14B.

Based on Marshall Wace's 13F filing for Q3 2015, filed 12 Nov 2015.